Press Releases June 9, 2026 08:00 AM

zSpace Technology Powers Breakthrough 3D Thyroid Reconstruction Research in Italy

zSpace Technology Enables Breakthrough AI-Driven 3D Thyroid Imaging Research in Italy

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
ZSPC

zSpace, Inc., a US-based AR/VR education technology company, announced its immersive platform's role in advancing medical imaging research in Italy. Partnering with L'ABCD Edutainment, zSpace technology facilitated the creation of AI-based 3D thyroid reconstructions from 2D ultrasound images without additional hardware, enabling improved visualization and diagnostic capabilities. This research, presented at Politecnico Milano, highlights zSpace's expansion into digital health innovation, leveraging AR/VR for enhanced medical imaging and AI-driven pathology classification.

zSpace Technology Powers Breakthrough 3D Thyroid Reconstruction Research in Italy
ZSPC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • zSpace's AR/VR platform enables detailed 3D thyroid models derived purely from 2D ultrasound images using AI algorithms, eliminating need for extra hardware.
  • The immersive platform supports both research and clinical decision-making by allowing interactive exploration of complex anatomical structures.
  • The project expands zSpace's footprint beyond education into medical and digital health sectors, showcasing potential for AI-enhanced diagnostics and visualization.
  • Sectors impacted include healthcare technology, digital health, medical imaging, AI in diagnostics, and AR/VR technology for education and medical research.

SAN JOSE, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- zSpace, Inc. (OTC: ZSPC), a leading provider of augmented and virtual reality (AR/VR) learning solutions for education, today announced that L'ABCD Edutainment, the exclusive Italian representative for zSpace technology, has leveraged the zSpace immersive platform to enable a significant advance in medical imaging research. Presented at the 3rd ANTHEM Scientific Meeting at Politecnico Milano, the research demonstrates how zSpace enables researchers to reconstruct and interactively explore 3D thyroid models derived entirely from 2D ultrasound images, without additional hardware sensors.

Traditional thyroid ultrasound imaging presents a fundamental challenge: 2D ecographic images lack complete geometric spatial information, and conventional 3D reconstruction approaches require sensors attached directly to the ultrasound probe, adding hardware complexity and cost. The L'ABCD Edutainment research team developed a software-only solution that eliminates that hardware dependency entirely.

Using artificial intelligence-based landmark identification algorithms, the team detects key anatomical reference points, including the carotid artery and trachea, directly from 2D ultrasound frames. These landmarks enable precise spatial registration of image sequences, producing a stack of aligned 2D frames that are then reconstructed into detailed 3D point cloud models of the thyroid. The zSpace platform serves as the visualization and interaction environment, allowing researchers and clinicians to manipulate, zoom, and explore anatomical structures in an immersive 3D space.

"The zSpace platform gives us the ability to bring complex anatomical reconstructions to life in a way that supports both research and clinical decision-making," said Nicola D'Ambrosio, Amministratore Unico, L'ABCD Edutainment. "By combining our AI-based imaging pipeline with zSpace's immersive environment, we are creating tools that can help identify pathological thyroid conditions earlier and more accurately."

The research extends beyond visualization. The team is developing AI-based deep learning models that classify healthy and pathological thyroid tissue by extracting intensity, shape, and textural features from both the original 2D ultrasound images and the reconstructed 3D models. This dual-source feature extraction approach improves the model's ability to differentiate between healthy thyroid tissue, thyroid with nodules, and inflammatory conditions such as thyroiditis.

"What L'ABCD Edutainment is demonstrating at Politecnico Milano is a compelling example of what becomes possible when immersive spatial technology is applied beyond the classroom. zSpace was built to make the unseeable visible and the untouchable interactive. Seeing that capability applied to medical imaging research that could improve patient outcomes is a powerful validation of what this platform can do," said Paul Kellenberger, CEO of zSpace. "We are proud to support the work L'ABCD Edutainment is advancing in Italy and look forward to the continued development of this research."

The research was presented as part of the 3rd ANTHEM Scientific Meeting, a multi-institutional initiative supported by the Italian Ministry of University and Research (Ministero dell'Università e della Ricerca) and conducted in collaboration with Politecnico Milano and the Centro Regionale Information Communication Technology (CeRICT). The project reflects Italy's growing investment in digital health innovation and AI-driven medical research.

L'ABCD Edutainment serves as the exclusive Italian partner for zSpace, supporting deployment, training, and implementation across educational and research institutions throughout Italy. This research represents an expansion of zSpace's European footprint into advanced medical research applications, complementing the company's established presence in K-12 and higher education institutions across the continent.

About zSpace
zSpace, Inc. (OTC: ZSPC) delivers innovative augmented and virtual reality (AR/VR) experiences that drive achievement in STEM, CTE, and career readiness programs. Trusted by over 3,500 school districts, technical centers, community colleges, and universities, zSpace enables hands-on "learning by doing" experiences proven to improve engagement and student outcomes. Headquartered in San Jose, California, zSpace holds more than 80 patents, with research published in the Journal of Computer Assisted Learning (2021) validating the impact of 3D virtual reality technologies on student knowledge gains.

Press Contact: Amanda Austin Senior Marketing Director, zSpace, Inc. [email protected]

Investor Relations Contact: Gateway Group Cody Slach, Greg Robles 949.574.3860 [email protected]


Risks

  • Technology adoption risk: Integration of immersive AR/VR medical imaging into clinical workflows may face resistance or slow adoption from medical practitioners.
  • Regulatory risk: Advances involving AI-driven medical imaging classifications are subject to stringent healthcare regulations and approvals in different jurisdictions, potentially delaying deployment.
  • Market risk: zSpace's expansion into healthcare applications may require significant investment and competitive positioning against established medical imaging technology providers, impacting financial outlook.

More from Press Releases

DSS, Inc. Withdraws Registration Statement Jun 9, 2026 TEN Ltd. Holds Its Thirty-Third Annual General Meeting of Shareholders Jun 9, 2026 American Airlines to webcast annual meeting of stockholders Jun 9, 2026 Datadog Launches 100+ Capabilities to Help Customers Drive Autonomy and Manage Growing AI and Security Complexity Jun 9, 2026 Decent Holding Inc. Forms Partnership with Taihao Robotics to Launch Real-World Robotics Training Network in China Jun 9, 2026